Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection
Brazil
BR112018008011-0
Filed on 2016-10-24
BR112018008011-0
Filed on 2016-10-24
NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE
Australia
2016349392
Filed on 2016-11-03
2016349392
Filed on 2016-11-03
NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE
South Africa
2018/02875
Filed on 2016-11-03
2018/02875
Filed on 2016-11-03
NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE
US Patent 11,236,152
Filed on 2018-04-30
Filed on 2018-04-30
NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE
India
201837016184
Filed on 2018-04-30
201837016184
Filed on 2018-04-30
NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE
European Patent
16801639.2
Filed on 2016-11-03
16801639.2
Filed on 2016-11-03
NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE
China
201680077520.X
Filed on 2016-11-03
201680077520.X
Filed on 2016-11-03
NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE
Canada
3003878
Filed on 2016-11-03
3003878
Filed on 2016-11-03
Zika Viral Antigen Constructs
Patent Cooperation Treaty
PCT/EP2017/079343
Filed on 2017-11-15
PCT/EP2017/079343
Filed on 2017-11-15